Aroa Biosurgery Limited (ASX:ARX)
Australia
· Delayed Price · Currency is AUD 0.575
-0.005 (-0.86%)
Feb 21, 2025, 4:10 PM AEST
Aroa Biosurgery Revenue
Aroa Biosurgery had revenue of 39.16M NZD in the half year ending September 30, 2024, with 33.47% growth. This brings the company's revenue in the last twelve months to 76.35M, up 15.87% year-over-year. In the fiscal year ending March 31, 2024, Aroa Biosurgery had annual revenue of 69.07M with 9.01% growth.
Revenue (ttm)
76.35M NZD
Revenue Growth
+15.87%
P/S Ratio
2.83
Revenue / Employee
n/a
Employees
n/a
Market Cap
198.32M AUD
Revenue Chart
* This company reports financials in NZD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 16.66B |
| Ansell | 3.00B |
| Mesoblast | 8.85M |
Aroa Biosurgery News
- 3 months ago - Aroa Biosurgery Ltd (ASX:ARX) H1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - GuruFocus